Eu­rope re­vokes one of Mod­er­na's Covid vac­cine patents fol­low­ing op­po­si­tion from BioN­Tech, Pfiz­er

In the Eu­ro­pean bat­tle­field of mR­NA lit­i­ga­tion, Mod­er­na took a blow af­ter the Eu­ro­pean Patent Of­fice de­clared one of its patents cov­er­ing its Covid-19 vac­cine in­valid ear­li­er this month fol­low­ing law­suits against BioN­Tech and Pfiz­er in mul­ti­ple coun­tries.

The ‘565 patent cov­ered “res­pi­ra­to­ry virus vac­cines,” in­clud­ing vac­cines for MERS and SARS, ac­cord­ing to the claim in the Eu­ro­pean Patent Of­fice.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER